GRID2IP and colorectal carcinoma: The therapeutic effect of GRID2IP as a therapeutic target lacks relevant reports or evidence support, and the signaling pathways involved in the occurrence and progression of CRC, as well as its upstream and downstream molecules, are not well-understood.